Dr. Connie L. Celum

powered by
COS Expertise®
University of Washington
School of Public Health and Community Medicine
Global Health
Director, International Clinical Research CenterAppointed: 2007
University of Washington
School of Public Health and Community Medicine
Global Health
ProfessorAppointed: 2007
University of Washington
School of Public Health and Community Medicine
Epidemiology
Adjunct ProfessorAppointed: 2003
University of Washington
School of Medicine
Medicine
Allergy and Infectious Diseases
ProfessorAppointed: 1992

Mailing Address

International Clinical Research Center (ICRC)
Department of Global Health
University of Washington
901 Boren Avenue, Suite 1300
Seattle, Washington 98104
United States

Contact Information

Phone: (206) 520-3825
Fax: (206) 520-3831
ccelum@u.washington.edu

Qualifications

M.P.H., University of Washington, 1989.
M.D., University of California School of Medicine, San Francisco, 1984.

Expertise and Research Interests

Dr. Celum's research currently focuses on HIV prevention, microbicide, and vaccine trials with the objective to find effective strategies to reduce HIV acquisition and transmission. She utilizes epidemiologic data on behavioral and biologic risk factors for HIV acquisition and transmission to identify potential intervention strategies and then to conduct randomized clinical trials to determine safety and efficacy of these interventions with biologic outcome measurements.

Her current focus is on HIV prevention trials, including genital herpes suppression for prevention of HIV acquisition, transmission and pre-exposure antiretroviral prophylaxis.
Dr. Celum is PI of a multi-center efficacy trial of HSV-2 suppression to reduce HIV infectiousness and HIV disease progression among HIV-discordant couples in Africa, and PI of a multi-center efficacy trial of pre-exposure antiretroviral prophylaxis among HIV discordant couples in Kenya and Uganda.

Keywords

COS Keywords:

AIDS, AIDS (Sexually Transmitted), Bacteria, Bacterial Infections, Education, Epidemiology, Herpes, HIV, Immunobiology, Immunology, Infectious Diseases Or Agents, Microbiology, Vaccine, Viral Studies.

Additional Terms:

AIDS, Bacteria/Bacterial Disease, Education/Training, Epidemiology, HHV8, HIV/SIV Infection, HSV, Herpes, Immunology/Immunobiology, Infectious Diseases, Lab Medicine, Microbicides, Microbiology, Treatment/Prevention, Viruses/Viral Disease.

Memberships

American College of Physicians
American Sexually Transmitted Disease Association
Infectious Diseases Society of America
Washington State Medical Association

Honors and Awards

1979-1984, Health policy research fellow, Dr. Philip Lee, of Health Policy Studies, University of California, San Francisco
1979, Phi Beta Kappa, Stanford University
1984, Alpha Omega Alpha, University of California, San Francisco
1984, Honorable mention, Gold-Headed Cane award for outstanding graduating medical student, University of California, San Francisco
2002, Mid-Career Women Faculty Professional Development Seminar, Association of American Medical Colleges
1981, Health Care Management Center award for research paper in health care management, University of Pennsylvania
1984, SmithKline Beckman Medical Perspectives Fellowship, National Fund for Medical Education

Publications

  • Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, Inambao M, Kanweka W, Allen S, Kiarie JN, Makhema J, Were E, Manongi R, Coetzee D, de Bruyn G, Delany-Moretlwe S, Magaret A, Mugo N, Mujugira A, Ndase P, Celum C (2008) Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial, PLoS ONE, 3 (1), e1411
  • Baeten JM, Celum C (2008) Syphilis, The Travel and Tropical Medicine Handbook, 4th ed, New York, W B Saunders Company, Chapter 38 pages (bookchapter)
  • Strick L, Marra C, Celum C (2007) Sexually transmitted diseases, AIDS Therapy, 3rd ed, Philadelphia, PA, Churchill Livingstone, Chapter 58 pages (bookchapter)
  • Zuckerman R, Lucchetti A, Whittington W, Sanchez J, Coombs R, Zuniga R, Magaret A, Wald A, Corey L, Celum D (2007) Herpes simplex virus (HSV) suppression with valacyclovir reduces blood plasma and rectal HIV-1 levels in HIV-1, HSV-2 seropositive men: A randomized, double-blind, placebo-controlled crossover trial, J Infect Dis, 196 (10), 1500-08
  • Sanchez J, Lama J, Kusunoki L, Manrique H, Goicochea P, Lucchetti A, Rouillon M, Pun M, Suarez L, Montano S, Hughes J, Celum C (2007) HIV-1, Sexually Transmitted Infection, and Sexual Behaviour Trends among Men who have Sex with Men in Lima, Peru, J Acquir Immune Defic Syndr, 44 (5), 578-85
  • Lingappa JR, Celum C (2007) Clinical and Therapeutic Issues for Herpes Simplex Virus-2 and HIV Co-infection, Drugs, 67 (2), 155-74
  • Baeten JM, Celum C (2006) Herpes Simplex Virus and HIV-1, HIV In Site Knowledge Base, http://hivinsite.ucsf.edu/InSite?page=kb-05-03-02 (bookchapter)
  • Lama JR, Lucchetti A, Suarez L, Laguna-Torres VA, Guanira JV, Pun M, Montano SM, Celum CL, Carr JK, Sanchez J, Bautista CT, Sanchez JL (2006) Association of herpes simplex virus type 2 and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru, J Infect Dis, 194, 1459-66
  • Whittington WLH, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL (2006) Partner-specific sexual behavioral differences between phase III HIV vaccine efficacy trial participants and controls: Project VISION, J Acquir Immune Defic Syndr, 43 (2), 234-8
  • Horton H, Havenar-Daughton C, Lee D, Moore E, Cao J, McNevin J, Andrus T, Zhu H, Rubin A, Zhu T, Celum C, McElrath J (2006) Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection, J Virol, 80 (19), 9779-88
  • Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C (2006) High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study, Am J of Epidemiology, 164 (8), 733-741
  • Strick LB, Wald A, Celum CL (2006) Management of herpes simplex virus type 2 infection in HIV type 1-infected persons, Clin Infect Dis, 43, 347-56
  • Kim HN, Meier A, Huang M-L, Kuntz S, Selke S, Celum C, Corey L, Wald A (2006) Oral Herpes Simplex Virus Type 2 reactivation in HIV-positive and HIV-negative men, J Infect Dis, 194 (4), 420-7
  • Lama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Guanira JV, Olson J, Sanchez JL, Whittington WLH, Celum CL, Grant RM (2006) Linking HIV and Antiretroviral Drug Resistance Surveillance in Peru: A Model for a Third Generation HIV Sentinel Surveillance, J Acquir Immune Defic Syndr, 42 (4), 501-5
  • Mulligan MJ, Russell ND, Celum CL, Allen M, Kahn J, Noonan E, Montefiori D, Ferrari G, Weinhold K, Smith JM, Amara R, Robinson HL (2006) Excellent Safety and Tolerability of the Human Immunodeficiency Virus Type 1 pGA2/JS2 Plasmid DNA Priming Vector Vaccine in HIV-1 Uninfected Adults, AIDS Research and Human Retroviruses, 22 (7), 678-83
  • Casper C, Carrell D, Pauk JS, Miller K, Judson FN, Morrow RA, Corey L, Wald A, Celum CL (2006) HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study, Sex Transm Dis, 82, 229-35
  • Liu H, Carrington M, Wang C, Holte S, Lee J, Greene B, Hladik F, Koelle DM, Wald A, Kurosawa K, Rinaldo CR, Celum C, Detels R, Corey L, McElrath MJ, Zhu T (2006) Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility, J Infect Dis, 193 (5), 698-702
  • Kim HN, Tabet SR, Corey L, Celum CL (2006) Antiretroviral Therapy for HIV-1 vaccine efficacy trial participants who seroconvert, Vaccine, 24 (4), 532-9
  • Celum CL, Robinson NJ, Cohen MS (2005) Potential effect of HIV-1 antiretroviral and herpes simplex type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection, J Infect Dis, 191 (Suppl 1), S107-14
  • Barton S, Celum C, Shacker TW (2005) The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic, Herpes, 12, 15-22
  • Colfax GN, Buchbinder SP, Vamshidar G, Celum CL, McKirnan DJ, Neidig J, Bartholow BN (2006) Motivations for trial participation and risk behavior among participants in an HIV vaccine efficacy trial, J Acquir Immune Defic Syndr, 39 (3), 359-64
  • Bartholow BN, Buchbinder SP, Celum CL, Goli V, Koblin BA, Para MF, Marmor M, Novak RM, Mayer KH, McKirnan, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD (2005) HIV sexual risk behavior over 36-months of follow-up in the world's first HIV vaccine efficacy trial, J Acquir Immune Defic Syndr, 39 (1), 90-101
  • Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum CL, Seage GR, 3rd (2005) Sexual risk, nitrate inhalant use, and lack of circumcision associated with HIV seroconversion among men who have sex with men in the United States, J Acquir Immune Defic Syndr, 39 (1), 82-9
  • Sagar M, Kirkegaard E, Long EM, Celum C, Buchbinder S, Daar ES, Overbaugh J, Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes, Journal of Virology, 78(13), 7279-83, 2004 Abstract
  • Colfax G, Vittinghoff E, Husnik MJ, McKirnan D, Buchbinder S, Koblin B, Celum C, Chesney M, Huang Y, Mayer K, Bozeman S, Judson FN, Bryant KJ, Coates TJ, EXPLORE Study Team, Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men, American Journal of Epidemiology, 159(10), 1002-12, 2004 Abstract
  • Celum CL, The interaction between herpes simplex virus and human immunodeficiency virus, Herpes: The Journal of the Ihmf, 11 Suppl 1, 36A-45A, April 2004
  • The Explore Team (inc Celum CL) (2004) Effects of a behavioral intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomized controlled study, The Lancet, 364, 41-50
  • Gorbach PM, Galea JT, Amani B, Shin A, Celum CL, Kerndt P, Golden MR (2004) Don't ask, don't tell: patterns of HIV disclosure among HIV positive men who have sex with men with recent STI practising high risk behaviour in Los Angeles and Seattle, Sex Transm Infect, 80 (6), 512-7
  • Liu H, Hwangbo Y, Holte SE, Lee J, Wang C, Kaupp N, Zhu H, Celum CL, Corey L, McElrath MJ, Zhu T (2004) Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1, J Infect Dis, 190 (6), 1055-8
  • Lee D, Graham BS, Chiu Y-L, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL (2004) Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160, J Infect Dis, 190 (5), 903-7
  • Zuckerman RA, Whittington WLH, Celum CL, Collis TK, Lucchetti AJ, Hughes JP, Sanchez JL, Coombs RW (2004) Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy, J Infect Dis, 190 (1), 156-161
  • Celum CL, Levine R, Weaver M, Wald A (2004) Genital herpes and human immunodeficiency virus: double trouble, Bull WHO, 82 (6), 447-453
  • Corey L, Wald A, Celum CL, Quinn TC (2004) The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics, J Acquir Immune Defic Syndr, 35 (5), 435-445
  • Baeten JM, Wang C, Celum CL (2004) Prevention of HIV, A guide to the clinical care of women with HIV, Rockville, MD, U.S. Department of Health and Human Services, 43-77 pages (bookchapter)
  • Zuckerman RA, Whittington WL, Celum CL, Collis T, Lucchetti A, Sanchez JL, Hughes JP, Sanchez JL, Coombs RW, Factors associated with oropharyngeal human immunodeficiency virus shedding, The Journal of Infectious Diseases, 188(1), 142-5, 2003 Abstract
  • Musey L, Ding Y, Elizaga M, Ha R, Celum C, McElrath MJ, HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals, Journal of Immunology (Baltimore, MD: 1950), 171(2), 1094-101, July 2003
  • Chesney MA, Koblin BA, Barresi PJ, Husnik MJ, Celum CL, Colfax G, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ, EXPLORE Study Team, An individually tailored intervention for HIV prevention: Baseline data from the EXPLORE Study, American Journal of Public Health, 93(6), 933-8, June 2003
  • Koblin BA, Chesney MA, Husnik MJ, Bozeman S, Celum CL, Buchbinder S, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ, EXPLORE Study Team, High-risk behaviors among men who have sex with men in 6 US cities: Baseline data from the EXPLORE Study, American Journal of Public Health, 93(6), 926-32, June 2003
  • Golden MR, Astete SG, Galvan R, Lucchetti A, Sanchez J, Celum CL, Whittington WL, Stamm WE, Holmes KK, Totten PA, Pilot study of COBAS PCR and ligase chain reaction for detection of rectal infections due to Chlamydia trachomatis, Journal of Clinical Microbiology, 41(5), 2174-5, 2003 Abstract
  • Spielberg F, Branson BM, Goldbaum GM, Lockhart D, Kurth A, Celum CL, Rossini A, Critchlow CW, Wood RW, Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men, Journal of Acquired Immune Deficiency Syndromes (1999), 32(3), 318-27, 2003 Abstract
  • Renzi C, Tabet SR, Stucky JA, Eaton N, Coletti AS, Surawicz CM, Agoff SN, Heagerty PJ, Gross M, Celum CL, Safety and acceptability of the Reality condom for anal sex among men who have sex with men, Aids (London, England), 17(5), 727-31, March 2003
  • Renzi C, Douglas JM Jr, Foster M, Critchlow CW, Ashley-Morrow R, Buchbinder SP, Koblin BA, McKirnan DJ, Mayer KH, Celum CL, Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men, The Journal of Infectious Diseases, 187(1), 19-25, 2003 Abstract
  • Tabet SR, Callahan MM, Mauck CK, Gai F, Coletti AS, Profy AT, Moench TR, Soto-Torres LE, Poindexter AN, 3rd, Frezieres RG, Walsh TL, Kelly CW, Richardson BA, Van Damme L, Celum CL (2003) Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men, J Acquir Immune Defic Syndr, 33 (4), 476-483
  • Celum CL, Marrazzo JM, Ocbamichael N, Meegan AM, Stamm WE (2003) The practitioner's handbook for the management of sexually transmitted diseases, 3rd Ed, Seattle, WA, Seattle STD/HIV Prevention Training Center, University of Washington
  • Whittington WL, Collis T, Dithmer-Schreck D, Handsfield HH, Shalit P, Wood RW, Holmes KK, Celum CL, Sexually transmitted diseases and human immunodeficiency virus-discordant partnerships among men who have sex with men, 35(8), 1010-7, October 2002
  • Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum CL, Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion, AIDS (London, England), 16(11), 1529-35, July 2002
  • Tabet SR, Sanchez J, Lama J, Goicochea P, Campos P, Rouillon M, Cairo JL, Ueda L, Watts D, Celum CL, Holmes KK, HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men, AIDS (London, England), 16(9), 1271-7, June 2002
  • Casper C, Wald A, Pauk J, Tabet SR, Corey L, Celum CL, Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men, Journal of Infectious Diseases, 185(7), 990-3, April 2002 Abstract
  • Sheppard HW, Celum CL, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP, HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion, Journal of Acquired Immune Deficiency Syndromes (1999), 29(3), 307-13, March 2002
  • Celum CL (2002) Syphilis, The travel and tropical medicine manual, 3rd ed, New York, W B Saunders Company, 429-38 pages (bookchapter)
  • Geise R, Maenza J, Celum CL, Clinical challenges and diagnostic approaches to recognizing acute human immunodeficiency virus infection, The American Journal of Medicine, 111(3), 237-8, August 2001 Abstract
  • Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum CL, Buchbinder S, Koblin B, Seage GR 3rd, HIV Network for Prevention Trials Vaccine Preparedness Protocol Team, Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection, Journal of Acquired Immune Deficiency Syndromes (1999), 27(5), 472-81, August 2001
  • Marrazzo JM, Whittington WL, Celum CL, Handsfield HH, Clark A, Cles L, Krekeler B, Stamm WE, Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics, Sexually Transmitted Diseases, 28(4), 219-25, April 2001 Abstract
  • Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum CL, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP, Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study, American Journal of Epidemiology, 153(7), 619-27, April 2001
  • Sucato G, Celum CL, Dithmer D, Ashley R, Wald A, Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents, The Pediatric Infectious Disease Journal, 20(4), 422-6, April 2001
  • Collis TK, Celum CL, The clinical manifestations and treatment of sexually transmitted diseases, Clin Infect Dis, 32(4), 611-22, February 2001
  • Whittington WL, Celum CL, Cent A, Ashley RL, Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics, Sexually Transmitted Diseases, 28(2), 99-104, February 2001 Abstract
  • Celum CL, Buchbinder SP, Donnell D, Douglas JM Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW, Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus, Journal of Infectious Diseases, 183(1), 23-35, Jan 2001 Abstract
  • Belshe RB, Stevens C, Gorse GJ, Buchbinder SP, Weinhold K, Sheppard HW, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege A-M, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum CL, Judson FN, Mayer KH, McKirnan DJ, Marmor M, Woody G, Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers, J Infect Dis, 183(9), 1343-52, 2001
  • Wang C, Celum CL (2001) Prevention of HIV, A guide to the clinical care of women with HIV, Rockville, MD, U.S. Department of Health and Human Services, 43-77 pages (bookchapter)
  • Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum CL, Selke S, Corey L, Mucosal shedding of human herpesvirus 8 in men, The New England Journal of Medicine, 343(19), 1369-77, November 2000
  • Lafferty WE, Downey L, Celum C, Wald A, Herpes simplex virus type 1 as a cause of genital herpes: Impact on surveillance and prevention, Journal of Infectious Diseases, 181(4), 1454-7, April 2000
  • Gorbach PM, Aral SO, Celum CL, Stoner BP, Whittington WL, Galea J, Coronado N, Connor S, Holmes KK, To notify or not to notify: STD patients' perspectives of partner notification in Seattle, Sexually Transmitted Diseases, 27(4), 193-200, April 2000
  • Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL, Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: Frequency, patterns, and risk factors [see comments, Clinical Infectious Diseases, 30(2), 261-7, 2000
  • Marrazzo JM (2000) Syphilis in women, Women and health, New York, Academic Press, 302-10 pages (bookchapter)
  • Tabet SR, Surawicz C, Horton S, Paradise M, Coletti AS, Gross M, Fleming TR, Buchbinder S, Haggitt RC, Levine H, Kelly CW, Celum CL, Safety and toxicity of nonoxynol-9 gel as a rectal microbicide, Sexually Transmitted Diseases, 26(10), 564-71, November 1999 Abstract
  • Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA, Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide, Sexually Transmitted Diseases, 26(10), 572-8, November 1999 Abstract
  • Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM, Use of reality 'female condoms' for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team, American Journal of Public Health, 89(11), 1739-41, November 1999 Abstract
  • Wang CC, Celum CL, Global risk of sexually transmitted diseases, Medical Clinics of North America, 83(4), 975-95 vi, July 1999 Abstract
  • Williams LA, Klausner JD, Whittington WL, Handsfield HH, Celum CL, Holmes KK, Elimination and reintroduction of primary and secondary syphilis [see comments, American Journal of Public Health, 89(7), 1093-7, July 1999
  • Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR, Buchbinder SP, Correlates of condom failure in a sexually active cohort of men who have sex with men, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(5), 495-501, 1999 Abstract
  • Celum CL, Buchbinder SP (1999) Counseling and testing for HIV infection, Sexually Transmitted Diseases, 3rd ed, New York, McGraw-Hill, 963-72 pages (bookchapter)
  • Tabet SR, Krone MR, Paradise MA, Corey L, Stamm WE, Celum CL, Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM), Aids, 12(15), 2041-8, October 1998 Abstract
  • Krone MR, Tabet SR, Paradise M, Wald A, Corey L, Celum CL, Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: Site and frequency of shedding, Journal of Infectious Diseases, 178(4), 978-82, October 1998
  • Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW, Cross-clade envelope glycoprotein 160-specific CD8 cytotoxic T lymphocyte responses in early HIV type 1 clade B infection, Aids Research and Human Retroviruses, 14(11), 925-37, July 1998 Abstract
  • Gross M, Buchbinder SP, Celum CL, Heagerty P, Seage GR, Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team, Sexually Transmitted Diseases, 25(6), 296-302, July 1998
  • Koblin BA, Heagerty P, Sheon A, Buchbinder S, Celum CL, Douglas JM, Gross M, Marmor M, Mayer K, Metzger D, Seage G, Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States, Aids, 12(7), 785-93, 1998
  • Celum C L, Bolan G, Krone M, Code K, Leone P, Spaulding C, Henry K, Clarke P, Smith M, Hook E W 3rd, Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity, Sexually Transmitted Diseases, 24(10), 599-605, November 1997
  • Marrazzo J M, White C L, Krekeler B, Celum C L, Lafferty W E, Stamm W E, Handsfield H H, Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay, Annals of Internal Medicine, 127(9), 796-803, 1 Nov 1997
  • Hook E W 3rd, Richey C M, Leone P, Bolan G, Spalding C, Henry K, Clarke P, Smith M, Celum C L, Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients. A potential contributor to continuing STD morbidity., Sexually Transmitted Diseases, 24(8), 443-8, September 1997 Abstract
  • Marrazzo J M, Fine D, Celum C L, DeLisle S, Handsfield H H, Selective screening for chlamydial infection in women: a comparison of three sets of criteria, Family Planning Perspectives, 29(4), 158-62, July 1997
  • Marrazzo J M, Celum C L, Hillis S D, Fine D, DeLisle S, Handsfield H H, Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy, Sexually Transmitted Diseases, 24(3), 131-41, March 1997
  • Celum CL (1997) Diagnosis and treatment of STDs in HIV-infected women, The medical management of AIDS in women, New York, Wiley-Liss, Inc, 235-51 pages (bookchapter)
  • Tabet SR, Celum CL (1997) Nongonococcal urethritis in men, Current diagnosis, 9th ed, Orlando, FL, W B Saunders Company, 703-4 pages (bookchapter)
  • Celum CL, Coombs RW (1996) Laboratory diagnosis of HIV, The HIV manual: a guide to diagnosis and treatment, New York, Oxford University Press, 28-30 pages (bookchapter)
  • Celum CL, Watts DH (1996) HIV and women, The HIV manual: a guide to diagnosis and treatment, New York, Oxford University Press, 120-7 pages (bookchapter)
  • Swenson PD, Lowens MS, Celum CL, Hierholzer JC., Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a STD clinic, Journal of Clinical Microbiology, 33, 2778-31, 1995
  • Tartaglione TA, Celum CL (1995) Sexually transmitted diseases, Applied therapeutics: the clinical use of drugs, 6th ed, Vancouver, WA, Applied Therapeutics, Inc., Chapter 64 pages (bookchapter)
  • Celum C L, Coombs R W, Jones M, Murphy V, Fisher L, Grant C, Corey L, Inui T, Wener M H, Holmes K K, Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study, Archives of Internal Medicine, 154(10), 1129-37, 23 May 1994
  • Marrazzo JM, Celum CL, Fine D (1994) Cost-effectiveness of selective vs. universal screening for Chlamydia trachomatis infection in women attending family planning and STD clinics, Chlamydial infections: Proceedings of the international symposium on human chlamydial infections, Chantilly, France, 63-6 pages
  • Compton S J, Celum C L, Lee C, Thompson D, Sumi S M, Fritsche T R, Coombs R W, Trichinosis with ventilatory failure and persistent myocarditis, Clinical Infectious Diseases, 16(4), 500-4, April 1993
  • Vitaliano PP, Russo J, Weber L, Celum CL., Dimensions of stress scale: Psychometric properties, Journal of Appl Soc Psych, 23, 1847-78, 1993
  • Celum CL, Coombs RW, Interpreting HIV-1 Western blot results, AIDS Reader, 3, 84, 89-91, 1993
  • Celum C L, Coombs R W, Indeterminate HIV-1 western blots: Implications and considerations for widespread HIV testing, Journal of General Internal Medicine, 7(6), 640-5, November 1992
  • Celum C L, Coombs R W, Lafferty W, Inui T S, Louie P H, Gates C A, McCreedy B J, Egan R, Grove T, Alexander S, et al, Indeterminate human immunodeficiency virus type 1 western blots: Seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation, Journal of Infectious Diseases, 164(4), 656-64, October 1991
  • Spach DA, Celum CL, Sheffield JV, et. al, native valve Corynebacterium Jeikeium endocarditis associated with a Denver Peritoneovenous Shunt, Archives of Dermatology, 127, 1071-2, 1991
  • Seaton T, Celum CL, Black D, Possible potentiation of Warfarin by Fluconazole, Annals of Pharmacotherapy, 24, 1177-88, 1990
  • Celum CL, Wood RW (1990) HIV: screening and counseling guidelines, AIDS Dx/Rx: a handbook for housestaff, New York, McGraw Hill, 79-91 pages (bookchapter)
  • Celum CL, Chaisson RE, Rutherford DW, Barnhardt JL, Echenberg DG, The incidence of salmonellosis in patients with the Acquired Immunodeficiency Syndrome, Journal of Infectious Diseases, 156, 998-1002, 1987
  • Celum CL, Newacheck P, Showstack J, Patterns of Medicaid Eligibility. A sample of 408 Medi-Cal eligibles in San Francisco County, CA, H Care Fin Rev, 2, 1-8, 1981

Profile Details

Last Updated: 3/17/2008

COS Expertise ID #135087
Reference this profile directly: http://myprofile.cos.com/CELUM